Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Evaluation of the Effect of Smoking on Pyroptosis in Periodontal Pathogenesis

28 april 2026 uppdaterad av: Meryem KOKSALAN, Suleyman Demirel University
This study investigates the impact of smoking on pyroptosis and inflammatory signaling pathways in systemically healthy individuals with various periodontal conditions. The research compares smokers and non-smokers across three clinical categories, resulting in six study groups: Healthy Control, Gingivitis, and Periodontitis. The study specifically evaluates the levels of IL-1beta, IL-18, and NLRP3 through ELISA, and the gene expression of TLR1, TLR4, and TLR6 through RT-PCR, to understand how cigarette smoke modulates innate immune responses in the absence of other systemic diseases.

Studieöversikt

Status

Aktiv, inte rekryterande

Detaljerad beskrivning

The aim of this research is to clarify the molecular link between tobacco use and pyroptotic cell death pathways in the pathogenesis of periodontal disease. To eliminate systemic bias, only systemically healthy participants are included. The study design consists of 6 distinct groups based on a 2x3 matrix (Smoking Status: Yes/No × Periodontal Status: Healthy/Gingivitis/Periodontitis).

Protein levels of the NLRP3 inflammasome and pro-inflammatory cytokines (IL-1beta, IL-18) are measured in periodontal tissues using the ELISA method. Furthermore, the mRNA expressions of Toll-like receptors (TLR1, TLR4, and TLR6) are analyzed via RT-PCR. These findings will help determine how smoking influences tissue destruction mechanisms specifically through the pyroptosis pathway in different stages of gum disease.

Studietyp

Observationell

Inskrivning (Faktisk)

113

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Isparta
      • Isparta, Isparta, Turkiet (Türkiye), 32000
        • Suleyman Demirel University, Faculty of Dentistry, Department of Periodontology

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Ja

Testmetod

Icke-sannolikhetsprov

Studera befolkning

The study population consists of individuals who applied to the Department of Periodontology at the Faculty of Dentistry. Participants include systemically healthy volunteers diagnosed with different periodontal conditions (healthy, gingivitis, or periodontitis) and categorized by their smoking status.

Beskrivning

Inclusion Criteria:

  • Individuals who voluntarily agreed to participate in the study,
  • Smokers (gingivitis and stage 3/4 generalized periodontitis) and non-smokers (gingivitis and stage 3/4 generalized periodontitis) who applied to the Periodontology Clinical of Suleyman Demirel University Faculty of Dentistry,
  • Individuals without any systemic diseases and without using any medications that affect periodontal health were included.

Exclusion Criteria:

  • Individuals who refuse to participate in the study or who cannot comply with the study protocol,
  • Individuals participating in another clinical trial concurrently, Individuals who have received periodontal treatment within the last 6 months,
  • Individuals who have used medications (antibiotics, anti-inflammatory drugs, etc.) that may affect periodontal parameters within the last 3 months,
  • Individuals with systemic diseases that may affect the periodontium,
  • Individuals with systemic diseases presenting with oral symptoms,
  • Individuals with malignant disease,
  • Pregnant or lactating women,
  • Individuals with psychological or physical disabilities,
  • Individuals with substance abuse,
  • Individuals with severe malocclusion, undergoing orthodontic treatment, using appliances, or using removable dentures,
  • Individuals with acute dental infection or pain (cavities, abscesses, etc.).

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Healthy Non-Smoker
Systemically healty individulas with clinically healthy periodontal tissues who have never smoked or have not smoked for least 5 years.
Gingivitis Non-Smoker
Systemically healty individulas diagnosed with gingivitis who are non-smokers.
Periodontitis Non-Smoker
Systemically healty individulas diagnosed with Stage III or IV periodontitis who are non-smokers.
Healthy Smoker
Systemically healty individulas with clinically healthy periodontal tissues who have been smoking least 10 cigarettes per day for at least 1 year.
Gingivitis Smoker
Systemically healty individulas with gingivitis who have been smoking least 10 cigarettes per day for at least 1 year.
Periodontitis Smoker
Systemically healty individulas diagnosed with Stage III or IV periodontitis who who have been smoking least 10 cigarettes per day for at least 1 year.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Relative mRNA expression levels of TLR1,TLR4 and TLR6
Tidsram: Baseline (At the clinical examination)
Metric:Fold change (2^-ΔΔCt method). Measurement of gene expression levels in gingival tissues using the RT-PCR method.
Baseline (At the clinical examination)
Protein concerntrations of NLRP3, IL-18 and IL-1β
Tidsram: Baseline (At the time of clinical examinat
Metric: Picograms per milliliter (pg/mL). Evaluation of protein concentrations in gingival tissue samples using the ELISA method.
Baseline (At the time of clinical examinat

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Periodontal Inflamed Surface Area (PISA)
Tidsram: Baseline (At the time of clinical examination)
Metric: square millimeters (mm²). Calculation of the total periodontal inflamed surface area to quantify the inflammatory burden.
Baseline (At the time of clinical examination)
Periodontal Clinical Measurements (PD and CAL)
Tidsram: Baseline (At the time of clinical examination)
Metric: millimeters (mm). Measurements of Probing Depth (PD) and Clinical Attachment Level (CAL) using a periodontal probe.
Baseline (At the time of clinical examination)
Periodontal Indices (PI and GI)
Tidsram: Baseline (At the time of clinical examination)
Metric: 0-3 numerical scale. Assessment of Plaque Index (PI) and Gingival Index (GI) to evaluate oral hygiene and gingival inflammation.
Baseline (At the time of clinical examination)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

15 oktober 2024

Primärt slutförande (Faktisk)

18 november 2025

Avslutad studie (Beräknad)

30 juni 2026

Studieregistreringsdatum

Först inskickad

11 april 2026

Först inskickad som uppfyllde QC-kriterierna

28 april 2026

Första postat (Faktisk)

1 maj 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

1 maj 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

28 april 2026

Senast verifierad

1 april 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera